Stocklytics Platform
Asset logo for symbol XBIT
XBiotech
XBIT66
$3.70arrow_drop_down4.41%-$0.16
Penny Stock
Asset logo for symbol XBIT
XBIT66

$3.70

arrow_drop_down4.41%

Income Statement (XBIT)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$4.80M-$14.96M-$10.85M-$8.19M-$7.45M
EBITDA-$4.36M-$14.53M-$10.42M-$8.15M-$7.02M
gross Profit--$435.00K-$432.00K$2.18M-$432.00K
NET Income-$5.01M-$13.00M-$10.00M-$4.63M-$7.36M
total Revenue$0.00$0.00$2.62M$2.62M$0.00

Balance Sheet (XBIT)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$173.11M-$178.53M-$191.03M-$200.02M-$202.19M
stockholders Equity$192.11M$196.70M$209.28M$218.84M$222.65M
total Assets$209.85M$215.55M$227.85M$227.24M$229.59M
total Debt$10.00M$10.00M$10.00M--
total Liabilities$17.73M$18.85M$18.57M$8.39M$6.94M

Cash Flow (XBIT)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$64.00K$48.00K$10.05M-$9.22M$5,000.00
free Cash Flow-$6.18M-$12.00M-$7.45M-$3.54M-$1.52M
investing Cash Flow-----
operating Cash Flow-$5.84M-$11.37M-$7.20M-$3.43M-$1.48M

XBiotech (XBIT) Financials

XBiotech Inc (XBIT) is a biotechnology company specializing in the development and commercialization of antibody therapies for treating diseases. The company's financials provide insight into its performance and financial health. The income statement reveals the company's revenue, expenses, and net income. XBiotech Inc's total revenue indicates the amount of money generated from its products and services. The gross profit represents the revenue minus the cost of goods sold, providing an indication of the company's profitability.
The company's net income from stockholders reflects the earnings that are distributed to its shareholders after deducting expenses and taxes. The balance sheet provides an overview of the company's assets, liabilities, and stockholders' equity. XBiotech Inc's total assets include cash, investments, property, and intellectual property rights. The total debt and liabilities represent the company's obligations, such as loans, leases, and payables.
Cash equivalents refer to highly liquid assets that can be easily converted into cash within a short time frame. XBiotech Inc's net debt reflects its total debt minus its cash and cash equivalents. Stockholders' equity represents the ownership interest of the company's shareholders, calculated as the difference between assets and liabilities. The cash flow statement details the company's cash inflows and outflows from various activities.
The financing cash flow section shows the cash generated or used from activities like issuing or repurchasing stock and paying dividends. The investing cash flow section indicates the cash flow from activities such as purchasing or selling long-term assets. The operating cash flow section provides insight into the company's cash generated or used in its day-to-day operations. XBiotech Inc's free cash flow represents the cash remaining after deducting capital expenditures from operating cash flow.
XBiotech Inc's financials, including income statement, balance sheet, and cash flow statement, are essential tools for investors and analysts to evaluate the company's financial performance and make informed investment decisions. Understanding these financial metrics helps assess the company's profitability, liquidity, leverage, and overall financial health.
add XBiotech  to watchlist

Keep an eye on XBiotech

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level